Intravenous fluid therapy in the perioperative and critical care setting: Executive summary of the International Fluid Academy (IFA)

Manu L. N. G. Malbrain, Thomas Länger, Djillali Annane, Luciano Gattinoni, Paul Elbers, Robert G. Hahn, I. De Laet, Andrea Minini, Adrian Wong, Can İnce, David James Jackson Muckart, Monty Mythen, Pietro Caironi, Niels Van RegenmortelAnnals 2020 · DOI

TL;DR

Intravenous fluid therapy, often overlooked, is a critical intervention that should be managed like any other drug, following a "4 Ds" approach (Drug, Dosing, Duration, De-escalation). This paper, an executive summary from the International Fluid Academy, advocates for a dynamic, phase-based approach (ROSE: Resuscitation, Optimization, Stabilization, Evacuation) to fluid management, emphasizing the avoidance of fluid overload and the use of balanced crystalloid solutions.

What Problem Does This Paper Address?

For decades, intravenous fluid administration has been a routine, almost unquestioned practice in perioperative and critical care. However, the medical community is increasingly recognizing that fluids are potent "drugs" with significant side effects, particularly fluid overload, which can lead to detrimental outcomes like acute kidney injury, pulmonary edema, and increased mortality. The challenge lies in moving beyond a one-size-fits-all approach to a more nuanced, individualized strategy that balances the need for adequate perfusion with the risks of excessive fluid administration. This paper addresses the need for a standardized, evidence-based framework for fluid management, akin to antibiotic stewardship, to optimize patient outcomes.

Methods

This paper is a comprehensive executive summary and review, synthesizing current evidence and expert consensus from the International Fluid Academy. It doesn't introduce novel experimental methods but rather consolidates existing knowledge into actionable guidelines. Key "methods" discussed include:

  • The "4 Ds" of Fluid Management: Analogous to antibiotic stewardship, fluid therapy should be guided by:
  • Drug: Selecting the appropriate fluid type based on indication.
  • Dosing: Administering the correct volume and rate.
  • Duration: Determining the appropriate length of therapy.
  • De-escalation: Actively withdrawing fluids when no longer needed.
  • The ROSE Concept: A dynamic, four-phase model for fluid management:
  • Resuscitation (R): Rapid fluid boluses to correct shock and achieve adequate perfusion.
  • Optimization (O): Fine-tuning fluid administration to maintain adequate tissue perfusion while avoiding overload.
  • Stabilization (S): Replacing ongoing losses and providing organ support with a neutral or negative fluid balance.
  • Evacuation (E): Actively removing excess fluid through diuresis or ultrafiltration.
  • Preference for Balanced Crystalloids: The paper strongly advocates for balanced crystalloid solutions (e.g., Plasma-Lyte, Lactated Ringer's) over normal saline (0.9% NaCl) due to their more favorable impact on acid-base balance and reduced risk of hyperchloremia and associated renal dysfunction.
  • Consideration of Colloids: While acknowledging the potential benefits of albumin in specific contexts, the paper highlights the lack of strong evidence for routine colloid use and concerns regarding semi-synthetic colloids.

Datasets

Not discussed in the paper. This is a review and consensus document, not an empirical study reporting on specific datasets used for training or evaluation.

Key Insights and Ideas

  • Fluid is a Drug: This fundamental shift in perspective is crucial. Treating fluids with the same rigor as antibiotics (drug selection, dosing, duration, de-escalation) is paramount.
  • Fluid Overload is a Major Harm: The paper repeatedly emphasizes the significant morbidity and mortality associated with excessive fluid administration, particularly in critically ill patients.
  • Balanced Crystalloids are Preferred: The physiological rationale and growing clinical evidence support balanced solutions over normal saline for most indications, especially to mitigate acid-base disturbances and renal injury.
  • Dynamic, Phased Approach is Essential: The ROSE concept provides a much-needed framework for managing fluid therapy across different stages of critical illness, moving from aggressive resuscitation to active fluid removal.
  • Individualization is Key: Fluid management must be tailored to the individual patient's needs, clinical condition, and response, rather than following rigid protocols without reassessment.
  • "Fluid Creep" is a Real Problem: The cumulative effect of small fluid administrations (e.g., for drug dilution, catheter patency) can lead to significant fluid overload over time.

Key Results

As a summary and consensus document, this paper doesn't present quantitative results from a single study. Instead, it synthesizes findings from numerous trials and observational studies. Key takeaways include:

  • Balanced solutions are associated with less acidosis and potentially better renal outcomes compared to normal saline.
  • Fluid overload is independently associated with increased mortality in ICU patients and surgical patients.
  • The ROSE concept provides a structured approach to fluid management, aiming to optimize perfusion while minimizing harm.
  • Albumin may have a role in specific situations (e.g., severe sepsis, burns) but is not a universal solution and is costly.
  • Semi-synthetic colloids (HES) are generally not recommended due to safety concerns.

Limitations and Future Work

  • Ongoing Debate on Colloids: While the paper leans towards crystalloids, the precise role and optimal use of colloids like albumin in specific patient populations (e.g., severe sepsis, burns) still require further investigation, with ongoing trials mentioned.
  • Defining "Optimal" Fluid Balance: While the ROSE concept provides phases, defining precise, universally applicable targets for each phase remains an area of active research and clinical judgment.
  • Individualized Monitoring: The paper stresses the importance of personalized monitoring, but the optimal combination and interpretation of various hemodynamic monitoring tools across different phases of illness require continued refinement.
  • Cost-Effectiveness: While balanced solutions are generally preferred for clinical reasons, economic factors can influence choices, and the paper acknowledges this.
  • Further Research on De-escalation: While the importance of de-escalation is highlighted, the optimal strategies and triggers for fluid removal require further study to avoid "over-deresuscitation."

Summary updated

Abstract

Intravenous fluid administration should be considered as any other pharmacological prescription. There are three main indications: resuscitation, replacement, and maintenance. Moreover, the impact of fluid administration as drug diluent or to preserve catheter patency, i.e., fluid creep, should also be considered. As for antibiotics, intravenous fluid administration should follow the four Ds: drug, dosing, duration, de-escalation. Among crystalloids, balanced solutions limit acid-base alterations and chloride load and should be preferred, as this likely prevents renal dysfunction. Among colloids, albumin, the only available natural colloid, may have beneficial effects. The last decade has seen growing interest in the potential harms related to fluid overloading. In the perioperative setting, appropriate fluid management that maintains adequate organ perfusion while limiting fluid administration should represent the standard of care. Protocols including a restrictive continuous fluid administration alongside bolus administration to achieve hemodynamic targets have been proposed. A similar approach should be considered also for critically ill patients, in whom increased endothelial permeability makes this strategy more relevant. Active de-escalation protocols may be necessary in a later phase. The R.O.S.E. conceptual model (Resuscitation, Optimization, Stabilization, Evacuation) summarizes accurately a dynamic approach to fluid therapy, maximizing benefits and minimizing harms. Even in specific categories of critically ill patients, i.e., with trauma or burns, fluid therapy should be carefully applied, considering the importance of their specific aims; maintaining peripheral oxygen delivery, while avoiding the consequences of fluid overload.
BibTeX
@article{malbrain2020intravenous,
  author = {Manu L. N. G. Malbrain and Thomas Länger and Djillali Annane and Luciano Gattinoni and Paul Elbers and Robert G. Hahn and I. De Laet and Andrea Minini and Adrian Wong and Can İnce and David James Jackson Muckart and Monty Mythen and Pietro Caironi and Niels Van Regenmortel},
  title = {{Intravenous fluid therapy in the perioperative and critical care setting: Executive summary of the International Fluid Academy (IFA)}},
  journal = {Annals},
  year = {2020},
  doi = {10.1186/s13613-020-00679-3},
}

Loading related content...

Figure